HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been given an average rating of “Moderate Buy” by the thirteen brokerages that are covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $113.54.

A number of equities research analysts recently commented on the company. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday, December 10th. Barrington Research upped their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Bank of America raised their target price on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Wells Fargo & Company boosted their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Royal Bank of Canada increased their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th.

HealthEquity Trading Up 2.6 %

HealthEquity stock opened at $109.76 on Monday. HealthEquity has a 1 year low of $65.01 and a 1 year high of $115.59. The firm’s 50 day moving average price is $104.84 and its 200-day moving average price is $93.08. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market cap of $9.51 billion, a P/E ratio of 100.70, a PEG ratio of 1.60 and a beta of 0.55.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the company earned $0.40 earnings per share. On average, equities analysts predict that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at $1,843,579.92. This trade represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,000 shares of company stock valued at $3,895,788. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HQY. Ameritas Investment Partners Inc. raised its position in HealthEquity by 0.3% during the 4th quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company’s stock valued at $3,248,000 after purchasing an additional 88 shares in the last quarter. Smartleaf Asset Management LLC increased its stake in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock valued at $37,000 after buying an additional 98 shares during the period. Louisiana State Employees Retirement System raised its holdings in shares of HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock valued at $2,322,000 after acquiring an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund lifted its stake in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock worth $1,706,000 after acquiring an additional 100 shares during the period. Finally, State of Michigan Retirement System grew its holdings in HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock worth $1,988,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.